Navigation Links
Sono-Tek Presents at the 15th International Coating Science and Technology Symposium (ISCST, St. Paul, MN)
Date:9/15/2010

MILTON, N.Y., Sept. 15 /PRNewswire/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK), Sono-Tek delivered a key address at the symposium of advanced coating technologies, whose aim is to present a program of cutting edge presentations on coating science and technology.  The symposium was attended by a cross section of industry leaders in advancing medical and energy projects and by academia from around the world.

Among the topics discussed were: polymer solar, layered nano structures, and biomedical advancements including the latest in anti-biofouling.  Sono-Tek's Director of Engineering, Mr. Robb Engle, presented "Advantages of Ultrasonic Spray Coating of BioMaterials onto Devices and Implantables".

The presentation was well received by major industrial leaders in the use of advanced coating processes.  Mr. Engle commented that he was pleased to find that so many of these sophisticated end users are already benefiting from the advantages of ultrasonic spray coating.  He added that, "During the exchanges we had in the symposium, we found many new opportunities to benefit the specialty coating community.  These opportunities can be readily served by Sono-Tek's existing line of ultrasonic coating systems."

Dr. Christopher L. Coccio, Sono-Tek Chairman and CEO, added: "Sono-Tek's success in the past 12 months can be directly attributed to our recent investments in developing technically superior, state-of-the-art spray coating systems, which provide unparalleled quality advantages and financial benefits."

For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com.

Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology.  Founded in 1975, the Company's products have long been recognized for their performance, quality, and reliability.

This press release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions, the ability to enforce patents and the ability to achieve increased sales volume and continued profitability. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-K and Form 10-Qs containing additional important information.


'/>"/>
SOURCE Sono-Tek Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sono-Tek Announces Second Quarter Results
2. CVS Caremark Presents Ongoing Behavioral Change Research Partnership Research to the Pittsburgh Business Group on Health
3. ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmins Potential to Transform the Treatment of Retinal Disorders
4. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
5. U.S. Ambulatory Electronic Health Record Market Presents Significant Opportunities and Risks for Vendors, Finds Frost & Sullivan
6. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
7. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
8. Reminder: ADVENTRX Presents Today at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference
9. Noscira Presents Results of Phase IIa Clinical Trial with Nypta(R) (Tideglusib) on Alzheimers Disease at International Conference on Alzheimers Disease (ICAD)
10. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
11. Tolerx Presents Baseline Data from DEFEND-1 Study Validating C-Peptide as Critical Clinical Measure for New-Onset Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2020)... Switzerland (PRWEB) , ... April 05, 2020 , ... ... has discovered and publicized the precise aetiology and pathology of COVID-19[1], we are ... of our COVID-19 clinical predictions. , The SARS-CoV-2-mediated post-entry suppression of ACE2 ...
(Date:4/2/2020)... ... April 02, 2020 , ... Caitlin Richardson, a ... Emergency Center's 2020 Spring Semester Scholarship. , The $1,000 scholarship, awarded biannually ... field, is aimed at helping the students pay tuition and other college-related expenses. ...
(Date:4/1/2020)... BIRMINGHAM, Ala. (PRWEB) , ... April 01, 2020 ... ... Care (AFC), the nation’s leading provider of urgent care and accessible primary ... The American Family network of nationwide healthcare clinics will now provide virtual visits, ...
Breaking Medicine Technology:
(Date:3/30/2020)... ... 30, 2020 , ... Achieve Medical Center now offers ... comprehensive and compassionate mental health and wellness services in the midst of the ... telemedicine services including initial consultations, evaluations, and follow-up care. It also allows patients ...
(Date:3/28/2020)... HOLMDEL, N.J. (PRWEB) , ... March 27, 2020 ... ... UAV services division of the Suntuity Group of companies, is mobilizing their drone ... the COVID-19 coronavirus. , By leveraging their DJI Enterprise level Matrice and Agras ...
(Date:3/28/2020)... ... March 27, 2020 , ... The construction industry is taking ... the coronavirus. Operating under the designation as an essential business as modified today ... protection projects in the downstate New York region. , While certain projects have ...
(Date:3/28/2020)... ... March 27, 2020 , ... Ahead of National ... edition of “The Fertility Journey.” This campaign will serve as a guide, showcasing ... maternal health options. , One in 6 couples experiences trouble with fertility. ...
(Date:3/28/2020)... ... March 28, 2020 , ... Confluent Health is proud ... therapist-owned rehabilitation company since 1985 specializing in the treatment of orthopedic, sports, and ... more than 30 years ago, we have been committed to providing excellent quality ...
Breaking Medicine News(10 mins):